TScan Therapeutics Announces Pricing of $140 Million Public Offering
Go back to TScan Therapeutics Announces Pricing of $140 Million Public Offering| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.37 -0.3 (44.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $26.80 | |||
| Open | $0.55 | 52 Week Low | $23.00 | |||
| Day High | $0.57 | P/E | N/A | |||
| Day Low | $0.36 | EPS | $0.00 | |||
| Volume | 6,121,644 | |||||
